David I. Silverman
Welwyn Garden City, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Journal: Ophthalmology
Published: August 09, 2023
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Journal: Ophthalmology
Published: August 09, 2023
Efficacy, Durability, and Safety of Faricimab in Patients From Asian Countries With Diabetic Macular Edema: 1-Year Subgroup Analysis of the Phase III YOSEMITE and RHINE Trials.
Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Published: March 31, 2023
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Journal: Lancet (London, England)
Published: August 31, 2021
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Journal: Lancet (London, England)
Published: August 31, 2021
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration.
Journal: Ophthalmology science
Published: June 11, 2021
YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale.
Journal: Ophthalmology science
Published: June 11, 2021
Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
Journal: Ophthalmology. Retina
Published: January 10, 2020
Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: August 07, 2019
Maximum Reading Speed in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Journal: Investigative ophthalmology & visual science
Published: November 02, 2018
Reliability and Construct Validity of the NEI VFQ-25 in a Subset of Patients With Geographic Atrophy From the Phase 2 Mahalo Study.
Journal: American journal of ophthalmology
Published: October 09, 2017
Last Updated: 09/26/2026